News & Events RSS Feed

4 May 2018

Personalised medicines will build on momentum from recent pharma deals

Dr Jim Millen, CEO of Physiomics, talks to Proactive Investors’ Andrew Scott about recent successes and the company’s future direction. Please click here to watch video

26 April 2018

Contract award

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is delighted to announce that it has been awarded a contract by a new UK based biotech client.  The value of the contract is £48k and it is expected to complete in this calendar […]

16 April 2018

Physiomics to Present at BioTrinity 2018

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it will attend BioTrinity 2018.  BioTrinity is one of Europe’s leading biopartnering and investment conferences, to be held on 23-25 April at the Novotel London West. Click here to […]

4 April 2018

Physiomics to Present at the American Association for Cancer Research (“AACR”) Annual Meeting

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it is participating in the AACR Annual Meeting 2018, taking place at the McCormick Place Convention Center, Chicago, Illinois, on 14-18 April 2018.  Dr Hitesh Mistry will present a […]

27 March 2018

Issue of Options

The Company considers that the award of options linked to company performance are critical to the incentivisation of its senior employees and to ensure that there is alignment between management and shareholders.  To this end, the Company today confirms that it has agreed to issue share options to its directors, as detailed in this announcement.  […]

14 March 2018

Award of New Innovate UK Grant

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens, is pleased to announce that is has been awarded a new grant by Innovate UK, the UK’s innovation agency.  The grant, awarded as part of Innovate UK’s Precision Medicine competition, will support the project “Prostate Cancer Chemotherapy Precision […]

12 March 2018

Completion of Innovate UK Grant Project on Personalised Treatment of Oesophageal Cancer

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to confirm that is has successfully completed the Innovate UK grant project announced in January 2017.  The project was formally signed off by Innovate UK following a final project meeting in February […]

Page 1 of 2512345...1020...Last